Common blood test identifies benefits and risks of steroid treatment in COVID-19 patients

(Albert Einstein College of Medicine) A new study led by Albert Einstein College of Medicine and Montefiore Health System (www.montefiore.org) confirms the findings of the large scale British trial of steroid use for COVID-19 patients and advances the research by answering several key questions: Which patients are most likely to benefit from steroid therapy? Could some of them be harmed? Can other formulations of steroids substitute for the agent studied in the British trial? The research was published today in the Journal of Hospital Medicine.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news